房颤流行病与医疗费用.pptVIP

房颤---流行病与医疗费用 首都医科大学附属北京安贞医院 马长生 房颤的患病率(ATRIA 研究) 不同研究中房颤的患病率 房颤患者的住院率 美国房颤患病率的发展趋势 中国房颤的发病率 中国---房颤的患病率 Crude prevalence 0.77% Age-standardized prevalence 0.65% male 0.66% ; female 0.63% 中国---房颤患者的年龄构成 中国---房颤的病因以及相关发病因素 中国---非瓣膜病房颤患者脑卒中发病率 中国---房颤/非房颤患者脑卒中的患病率 房颤患者的抗栓治疗和脑卒中发生率 房颤年度医疗花费的构成 不同因素对房颤治疗价/效关系的影响 房颤导管消融与药物治疗医疗费用的比较 房颤医疗费用的构成 房颤消融前后对医疗资源占用的比较 Preablation examinations: CT、TEE、TTE、biochemical test Catheter ablation： Abl catheter、Reference pad、Lasso catheter Postablation medication Warfarin、Amiodarone Atrial fibrillation： The Epidemic and Cost Changsheng Ma, M.D. Department of Cardiology Beijing Anzhen Hospital, Capital Medical University Beijing, P.R. China Dem 13, 2008 Prevalence of Diagnosed AF(ATRIA study) Prevalence of AF in population-based studies Prevalence of hospitalizations for AF Projected Number of AF in U.S Incidence of AF in China Prevalence of AF in China Crude prevalence 0.77% Age-standardized prevalence 0.65% male 0.66% ; female 0.63% Age distribution of patients with AF Causes and associated factors for AF Incidence of Stroke in patients with NVAF Prevalence of stroke in AF/non-AF cohorts Antithrombotic treatment and stroke rate in AF Distribution of annual costs of AF Influence of variables on cost/effectiveness of AF therapy Costs of Ablation vs Medication of AF Distribution of costs of care in AF in the societal perspective Comparison of healthcare resource utilization before and after ablation Preablation examinations: CT、TEE、TTE、biochemical test Catheter ablation： Abl catheter、Reference pad、Lasso catheter Postablation medication Warfarin、Amiodarone Int J Cardiol 2005; 283 Chin J Cardiol 2002;165 Incidence of Stroke (/year) % 29079 28855 224 Total subjects (n) 2.36 2.28 12.95 Prevalence of stroke (%) 28368 28173 195 Non-stroke (n) 686 Sum 657 Non-AF 29 AF Stroke (n) J Epidemiol 2008; 20